Blueprint Medicines blueprintmedicines.com


Blueprint Medicines is a patient-driven oncology company discovering and developing highly selective kinase inhibitors for genomically defined cancers. Led by a management team and advisors with world renowned expertise in cancer genomics, drug discovery and clinical oncology, Blueprint Medicines has developed a platform that combines genomics with a novel small molecule library of kinase inhibitors, enabling Blueprint Medicines to rapidly discover potent and highly selective drugs against clear...Show all

Blueprint Medicines is a patient-driven oncology company discovering and developing highly selective kinase inhibitors for genomically defined cancers. Led by a management team and advisors with world renowned expertise in cancer genomics, drug disco...Show all

Company (IPO / Went public)

Phone: 617-374-7580

Fax:

215 First Street

Cambridge, 02142
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Blueprint Medicines $277.2M Apr 30, 2015

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Blueprint Medicines Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 14 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Compositions useful for treating disorders related to kit Mar 14, 2014 Nov 22, 2016 Patent
Inhibitors of the fibroblast growth factor receptor Apr 02, 2015 May 17, 2016 Patent
Compositions useful for treating disorders related to kit Oct 17, 2014 May 10, 2016 Patent
Compositions useful for treating disorders related to kit Oct 15, 2014 Dec 01, 2015 Patent
Inhibitors of the fibroblast growth factor receptor Jun 27, 2014 Sep 08, 2015 Patent
See all 21 patents